Background and objective: Hyperglycemia leads to adaptive cell responses in part due to hyperosmolarity. In endothelial and epithelial cells, hyperosmolarity induces aquaporin-1 (AQP1) which plays a role in cytoskeletal remodeling, cell proliferation and migration. Whether such impairments also occur in human induced pluripotent stem cells (iPS) is not known. We therefore investigated whether high glucose-induced hyperosmolarity impacts proliferation, migration, expression of pluripotency markers and actin skeleton remodeling in iPS cells in an AQP1-dependent manner. Methods and results: Human iPS cells were generated from skin fibroblasts by lentiviral transduction of four reprogramming factors (Oct4, Sox2, Klf4, c-Myc). After reprogramming, iPS cells were characterized by their adaptive responses to high glucose-induced hyperosmolarity by incubation with 5.5 mmol/L glucose, high glucose (HG) at 30.5 mM, or with the hyperosmolar control mannitol (HM). Exposure to either HG or HM increased the expression of AQP1. AQP1 co-immunoprecipitated with β-catenin. HG and HM induced the expression of β-catenin. Under these conditions, iPS cells showed increased ratios of F-actin to Gactin and formed increased tubing networks. Inhibition of AQP1 with small interfering RNA (siRNA) reverted the inducing effects of HG and HM. Conclusions: High glucose enhances human iPS cell proliferation and cytoskeletal remodeling due to hyperosmolarity-induced upregulation of AQP1.
Introduction
Transplantation of stem cells is emerging as a promising strategy for the repair and regeneration of damaged organs or tissues, including those in the cardiovascular system [1] . However, major limitations remain for the use of adult stem cells harvested from essential organs, including the paucity, immunogenicity and low potency of adult stem cells. Advances in stem cell biology have recently offered new opportunities for regenerative therapies, enabling the generation of induced pluripotent stem (iPS) cells [2, 3] or even induced cardiomyocytes [4] from somatic cells of readily obtainable human tissue source. However an issue has been raised on a potentially lower yield of iPS cells obtained from patients in need of them, because disease or aging may render the reprogramming process of iPS cells from somatic cells less efficient, particularly when the original stem cell preparation is of poor quality [5] [6] [7] [8] [9] .
It is therefore of importance to determine whether and to what extent pathophysiological conditions, such as those occurring in diabetes, impair iPS cells, or create a microenvironment harmful or hostile for the subsequent iPS cell implantation. Recent studies have indeed documented that biophysical factors, including hyperosmolarity, as occurring in diabetic hyperglycemia, may represent important regulatory elements influencing stem cell fate, both in physiological and pathological conditions [10] [11] [12] [13] . In the diabetic setting, hyperglycemia has been indeed shown to be involved in the control of stem and progenitor cell fate and cell reprogramming [14] [15] [16] [17] [18] .
In addition to being a macronutrient and a metabolic regulator, glucose is an osmotically active molecule. While the effects of hyperosmolarity have been extensively studied in adult cultured cells, demonstrating changes in cell shape, nutrient transport, proliferation and growth [19] [20] [21] [22] [23] , nothing is known on its effects on the properties and fate of iPS cells in in vitro conditions mimicking diabetes.
Against this background, we therefore hypothesized that diseaserelated changes may affect the somatic reprogramming of iPS cells. Consequently, we aimed at specifically investigating the cellular response of iPS cells to high glucose-induced hyperosmolarity, pursuing an analysis of iPS cell growth, migration, actin skeleton remodeling and expression of pluripotency markers in response to one biophysical conditionincreased osmolaritymimicking that occurring in diabetic hyperglycemia.
Materials and methods

Reagents
D-Glucose, D-mannitol (devoid of metabolic activities and used as a purely hyperosmolar control), and all other chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA), unless otherwise specified.
iPS cell generation
Human foreskin fibroblasts [purchased from American Type Culture Collection (ATCC, Manassas, VA, USA)] were used to establish human iPS cells. Lentiviral vectors expressing 4 reprogramming transcription factorsoctamer-binding transcription factor (OCT)-4, sex determining region Y (SRY)-box 2 (SOX2), Kruppel-like factor (KLF)-4, and c-MYCand green fluorescence protein (GFP) as a reporter gene under the control of the human elongation factor-1 alpha promoter (EF1μ) were purchased from Open Biosystems (ThermoFisher Scientific, Huntsville, AL, USA). Fibroblasts were seeded at 1.5 × 10 4 cells/cm 2 in 24-well plates in Eagle's Minimum Essential Medium (MEM) supplemented with 10% fetal bovine serum (FBS). At 30-40% confluence, cells were transduced with equal amounts of particles (at multiplicity of infection (MOI) of 1:10) of the lentiviral vectors encoding the four transcription factors (average titer: 5 × 10 8 transducing units (TU)/mL), for a total MOI of 40 delivered to target cells. Cells were then maintained in embryonic stem cell (ES)-specific medium (from Stem Cell Biotechnology, Vancouver, Canada). Following 2 to 3 weeks of culture in enriched natural seawater (ES) medium, compact ES-like colonies emerged among a background of fibroblasts, and colonies with ES cell morphology were manually picked and transferred to new dishes for further experiments (online Supplement Fig. 1 ). The iPS cell lines were confirmed by teratoma formation assay and for the positivity of OCT-4, SOX2, KLF-4 and Nanog by immunoblotting. More than three reprogramming experiments were performed and at least three clones for each experiment were analyzed. The iPS cells were stored in liquid nitrogen until further experiments.
Experimental design
Human iPS cells were characterized for their adaptive responses to high glucose-and high mannitol-induced hyperosmolarity for up to 24 h ( Fig. 1 ). After thawing, the iPS cells were let to recover by plating them in ES-specific medium. After reaching 70% confluency, cells were synchronized to be in the same cell-cycle phase by starvation in lowglucose (5.5 mM) Dulbecco's Modified Eagle Medium (DMEM) containing 2% fetal calf serum (FCS) for 24 h. After synchronization, iPS cells were separated into 5 groups and incubated with control glucose concentration (5.5 mM, control), high glucose (HG, 30.5 mM, respectively), or high mannitol (HM, 5.5 mM glucose + 25 mM mannitol, respectively) up to 24 h in separate experiments, respectively ( Fig. 1 ). After osmotic stress conditions, cells from all the 3 groups were collected for in vitro assays as follows. Cell size, water permeability and cell proliferation were monitored at different time points (0-15-30-60 s, 15 min, and 1 and 24 h), while protein expression of different targets (KLF-4, SOX-2, Nanog, OCT, GAPDH, G-actin, F-actin, AQP1, β-catenin) as well as flow-cytometry analyses of AQP1 expression (online Supplement Figs. 2 and 3), migration assays in Matrigel and visualization of the Factin cytoskeleton were assessed after 24 h. In some preliminary experiments, cell volume was also measured at different osmotic environments (HG at 17.5, 50.5, 105.5 and 185.5 mM and corresponding HM iPS cells pre-incubated with scrambled siRNA or siRNA-AQP1 in starvation medium (2%FCS/5.5 mM Glu-DMEM) concentrations). During the 24 h incubation period, cells were maintained in OptiMem reduced serum medium (Invitrogen) to avoid the cell detachment and death due to starvation. Basal DMEM or OptiMem media have an inorganic salt concentration of 120 mM, a glucose (or mannitol) concentration of 5.5 mM, and an osmolality in the range of 322-374 mOsm/kg of H 2 O. After osmotic stress and control conditions, cell viability was assessed by cell morphology and cell count using phase-contrast microscopy, Trypan blue exclusion and total protein content. Cell proliferation was assessed by determining the GFP-positive cells using a POLARstar OPTIMA plate reader (BMG Labtechnologies, Offenburg, Germany). Green fluorescence emission with an emission peak of 523 nm was detected. Cell size was assessed using a Multisizer ™ 3 Coulter counter equipped with a Channelyzer (Beckman Coulter, Miami, FL, USA). The number of GFP-positive cells was assessed using a FACSCalibur flow cytometer (BD Biosciences, CA, USA).
Fluorescence-activated cell sorting (FACS) analysis of reprogrammed cells
Dissociated ES-like colonies were plated in serum-starved in low glucose DMEM containing 2% FCS for 24 h, and then incubated with control glucose (5.5 mM, control), high glucose (HG, 30.5 mM), or high mannitol (HM, 5.5 mM glucose + 25 mM mannitol) for 24 h. To quantify the number of GFP-positive cells and AQP1-positive cells, after incubation, iPS cells were incubated with the AQP1 primary antibody (Santa Cruz) followed by secondary antibody (anti-mouse IgG + the PerCP-CY5 fluorophore), then sorted using FACS (FACSCalibur flow cytometer, Becton Dickinson, BD). See online Supplement for further details.
Transfection of AQP1 siRNA
A pool of three different small interfering RNA (siRNA) oligonucleotides against AQP1 conjugated with cyan (Cy)-5 or scrambled control siRNAs were obtained from Ambion (Invitrogen). Cells (2 × 10 5 /well) were plated on 6-well plates in low-serum medium without antibiotics (OptiMem) and incubated with 6 μL of siRNA transfection reagent mixed with siRNAs (60 μmol/L) up to a total volume of 800 μL transfection medium. After 24 h, a fresh medium was added with or without glucose or mannitol (5.5 or 30.5 mM) and incubated for an additional 24 h; cells were then harvested using ethylenediaminetetraacetic acid (EDTA)/phosphate buffered saline (PBS) without trypsin, and proteins were extracted for further experiments.
Migration assays
Migration assays were performed with Matrigel in 96-well plates (BD Biosciences, San Jose, CA, USA), allowing the formation of both tubules and a vascular-like network. Before the assay, human control fibroblasts or human iPS cells were grown for 24 h in endothelial basal medium (EBM, BD Biosciences) without endothelial growth factors, supplemented with 2.5% FBS and control concentrations of glucose (5.5 mM, control), and then shifted to the same medium with either control glucose (5.5 mM, control), high glucose (30.5 mM) or high mannitol (5.5 mM glucose + 25 mM mannitol, or with siRNA to AQP1) and plated on Matrigel (at a density of 2 × 10 5 cells/50 μL of Matrigel) for further 24 h. Images were acquired in Normaski mode with red and green channels using a 10 × objective on an immunofluorescence microscope (Leica, Wetzlar, Germany), and pictures were taken by an attached digital output Olympus camera. Several tube formation indices (tube areas, tube length, and tube number) were quantified using the National Institutes of Health (NIH) Image software (version 1.62).
Immunoprecipitation and immunoblotting
Total proteins were isolated in ice-cold radioimmunoprecipitation (RIPA) buffer [24] . Proteins were separated under reducing conditions and electroblotted onto polyvinylidene fluoride membranes (Immobilon-P; Millipore, Bedford, MA, USA). After blocking, the membranes were incubated overnight at 4°C with the following primary antibodies: (1) AQP1 (Santa Cruz), (2) β-actin (Sigma), (3) β-catenin (Cell Signaling, Billerica, MA, USA), (4) KLF-4 (Cell Signaling), (5) Sox-2 (Cell Signaling), (6) Nanog (Cell Signaling), and (7) OCT-4 (Cell Signaling). Equal loading/equal protein transfers were verified by stripping and re-probing each blot with an anti-GAPDH antibody. For immunoprecipitation, cell lysates were mixed with the monoclonal mouse anti-AQP1 antibody and the immunocomplexes were pulled down with protein-A/G beads (Santa Cruz). The immunoprecipitants were then eluted, concentrated and subjected to immunoblotting for AQP or β-catenin.
Fluorescence-quenching assay
A fluorescence quenching assay was performed according to a previously published protocol [25] . Here, iPS cells were seeded on black, clear-bottomed plates (Corning), grown for 2 days at 37°C, 5% CO 2 and 95% relative humidity, and loaded with calcein-AM ester (BD Biosciences). Before loading the cells with the calcein-AM ester in assay buffer (0.8 mM MgSO 4 , 5 mM KCl, 1.8 mM CaCl 2 , 25 mM Na-HEPES, pH adjusted to 7.4 with HCl), the growth medium was exchanged with the fresh medium for 1 h. All assay plates were washed with a fresh assay buffer, and then treated with the osmolytes (glucose or mannitol) ranging in concentrations between 5.5 and 30.5 mM. Calcein fluorescence was recorded on a Fluostar Optima plate reader (BMG LABTECH, Ortenberg, Germany) equipped with a 495-nm band-pass filter for excitation and a 520-nm long-pass filter for emission. Osmotic gradients were applied 5 s after the beginning of each baseline reading through the instrument. Dynamic changes in fluorescence intensity were recorded for an additional 15, 30 and 60 s, 15 min, 1 and 24 h.
Visualization of the F-actin cytoskeleton
F-actin incorporated into the cytoskeleton was visualized in iPS cells grown on cover slips, after permeabilization and incubation with phalloidin (rhodamine). iPS cells were grown on cover slips at a density of 30,000 cells per cover slip. After stimulation with an isotonic solution (105 mM NaCl, 6 mM KCl, 1 mM MgCl 2 , 1.5 mM CaCl 2 , 10 mM HEPES, 5.5 mM glucose, adjusted to pH 7.4 with NaOH) or a hypertonic solution (105 mM NaCl, 6 mM KCl, 1 mM MgCl 2 , 1.5 mM CaCl 2 , 10 mM HEPES, 30.5 mM glucose or 5.5 mM glucose/25 mM mannitol, adjusted to pH 7.4 with NaOH) for 24 h, cells were fixed in 3.7% fresh formaldehyde for 15 min at room temperature, washed twice, and permeabilized in 0.2% Triton X-100. After permeabilization, cells were incubated in 14 μM phalloidin (rhodamine) (Acti-stain 535, 1:100 dilution, purchased from Cytoskeleton Inc, Denver, CO, USA) for 40 min at room temperature. Stained samples were treated with Vectashield/DAPI mounting medium for fluorescence to retard photobleaching. All incubation and washing steps were performed in TRIS-buffer (TBS, 10 mM Tris-HCl, pH 7.3, 150 mM NaCl, 1 mM MgCl 2 and 1 mM EGTA) at room temperature.
Measurement of monomeric and polymeric F-and G-actin
Quantitation of the ratio of F-actin incorporated into the cytoskeleton to G-actin found in the cytosol was performed using a G-actin/F-actin assay kit (Cytoskeleton Inc, Denver, CO, USA) according to the manufacturer's instructions. In brief, iPS cells were homogenized in an F-actin stabilization buffer, and then centrifuged to separate the F-actin from the G-actin pool. The fractions were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and actin was quantified using Western blotting.
Statistical analysis
Two-group comparisons were performed using the Student's t-test for unpaired values. Multiple-group comparisons were made using analysis of variance (ANOVA), and the existence of individual differences, in case of significant F-values at ANOVA, tested by Scheffé's multiple contrasts. A P-value of less than 0.05 was considered significant.
Results
High glucose-induced hyperosmolarity impacts cell size and water permeability of human induced pluripotent stem cells
We tested the effect of hyperosmolarity on iPS cell size by incubating iPS cells with high glucose (HG) and high mannitol (HM), the latter devoid of glucose metabolic effects but increasing extracellular osmolarity to the same extent as high glucose. Cell size (as measured by diameter) changes in iPS cells in response to changes in extracellular osmolarity were assessed in suspended cells using a Coulter counter. Cell size measurements as shown in Fig. 2A were recorded at different time points (0-15-30-60 s, at 15 min, at 1 and 24 h) after exposure to a hyperosmolar medium by the addition of HG or HM (30.5 mM), and 60 s after a shift in extracellular osmolarity from iso-osmotic concentrations (5.5 mM) to a range of concentration with higher osmolarities (from 12.5 to 185.5 mM) (online Supplement Fig. 4A and B ). Increasing osmolarity with HG or HM up to 30.5 mmol/L for 60 s caused a significant increase in cell size, while further increases in osmolarity decreased cell size (online Supplement Fig. 4A and B ). No significant changes in cell size were recorded after 15 s and 30 s loading HG (30.5 mM glucose) or HM (5.5 mM glucose + 25 mM mannitol), while stable cell shrinking was observed after 15 min, 1 and 24 h ( Fig. 2A) .
To further analyze the effects of hyperosmolarity on iPS cells in terms of water permeability, we implemented a functional assay based upon calcein fluorescence quenching, a well-established method for the measurement of rapid osmosis in monolayers of cultured cells [26] . Cultured cells in the 96-well format were loaded with calcein-AM, a membrane-permeable calcein derivative that is cleaved intracellularly by esterases to become trapped in the cytoplasm. The functional assay of iPS cells was performed in a fluorimetric plate reader as described in the Materials and methods section. Cells were rinsed in 50 μL of isosmolar PBS. The extent of fluorescence change (expression of the movement of calcein from inside to outside of the cell through osmotic gradients) was determined using the ratio between fluorescence before (Ft) and after (F 0 ) a change in the extracellular osmolyte (glucose or mannitol) concentrations ( Fig. 2B ). Cell volume and permeability changes in response to osmotic gradients can be rapid if facilitators of water permeability, such as AQP1, are present [27] . Following very short incubations (15, 30 and 60 s), calcein quenching in response to osmolytes became clearly visible. After 60 s, fluorescence intensity appeared to be at equilibrium, and we did not observe any further fluorescence intensity changes up to 15 min that could indicate changes in cellular osmolyte permeability ( Fig. 2B) . We tested the response of iPS cells to the addition of osmotic shifts from isosmotic (5.5 mM) to a final extracellular osmolarity of 30.5 mM. We observed significant differences after loading HG (30.5 mM glucose) or HM (5.5 mM glucose + 25 mM mannitol) for 30 s (p b 0.01) and 60 s (p b 0.05) ( Fig. 2B ). Thus, iPS cells appear osmotically sensitive because they are able to sense and respond to hyperosmolarity by changing their size and water permeability.
High glucose but not high mannitol drives the expression of pluripotency markers in human induced pluripotent stem cells
To investigate whether environmental cues such as high glucoseinduced hyperosmolarity impact the expression of pluripotency markers of iPS cells, we determined the differences in expression of KLF-4, Sox-2, Nanog and OCT-4 among experimental conditions tested ( Fig. 3 ). Twenty-four hour exposure to HG (30.5 mM)but not HM (5.5 mM glucose + 25 mM mannitol)changed protein expression of KLF-4 with a 2.8-fold increase, with 1.5 increase of OCT-4, and a near-doubling of Nanog and SOX-2, as determined by Western analysis (Fig. 3 ). Thus, hyperosmolarity per se does not appear to impact markers of the pluripotency potential of iPS cells. In parallel experiments, cells were also incubated with sodium chloride and saccharose at equimolar concentrations, as further osmotic control, and similar results were obtained.
High glucose induces cell proliferation of human induced pluripotent stem cells through a hyperosmolar mechanism
To evaluate whether increased levels of pluripotency markers translate into increased cell proliferation, differences in cell numbers between the different conditions were determined. Data reported in Fig. 4 were obtained by analyzing the expression of the green fluorescence protein (GFP) reporter gene in iPS cells after 1 h and 24 h exposures to a hyperosmolar medium by the addition of glucose or mannitol (30.5 mM). As shown in Fig. 4A and B , the rate of cell 
Exposure of iPS cells to high glucose or high mannitol induces the formation of osmopodia
Under isotonic conditions (5.5 mM glucose), iPS cells appeared rounded and organized in compact ES-like colonies, with visible stress fibers (stained in red) running through the cytosol (Fig. 5A ). However, their morphology and spatial organization changed markedly when exposed to a hyperosmolar medium. In HG or HM, the initial cellular response was a decreased cell volume. Cells shrank rapidly (with the shrinking process being completed in a few second). The cells then started extending cytoplasmic protrusions termed osmopodia [28] . The osmopodia extension process started after 10 min in medium at 30.5 mM of osmolyte concentration (physiological osmolality is 286 mOsm, which is produced by 5.5 mM glucose concentration). Fig. 5 shows osmopodia formation from iPS cells at 30.5 mM hyperosmolarity. Podia extension was rare in an isotonic medium (panel A). However, as the osmolarity of medium increased (panels A-D), the frequency and length of the podia increased dramatically, documenting the induction of the osmopodia by hyperosmolarity. The length and number of osmopodia per cell and the dynamics of osmopodia extension were variable even in a homogeneous iPS cell population. Some cells began osmopodia extension as soon as they completed the shrinking process, while others responded slowly to osmotic stress, causing a diverse distribution of osmopodia lengths. The number of osmopodia extending to a noticeable size per cell ranged from one to five. Based on cellular volume change as an initial cellular response to the abrupt osmolarity shift, we investigated osmotically activated ion and water transport mechanisms across the cellular membrane. During preliminary experiments observing morphological changes in cells in a drop of cell suspension on a glass slide, we found that fluorescently labeled cells (GFP-positive iPS cells), particularly those located near the edge of the drop, showed a significant increase in osmopodia forming frequency. Almost all suspended cells exhibited hyperosmolarity-induced osmopodia extension. The actin skeleton is known to play a crucial role in cell protrusion and changes in cell volume and shape [29] . It was therefore conceivable that hyperosmolarity exerts its effect on osmopodia formation through a perturbation of the actin skeleton. To assess the effect of hyperosmolarity on the actin skeleton, iPS cells and osmopodia in either an isotonic of a hyperosmolar medium were stained in situ after fixation with rhodamine-conjugated phalloidin, which specifically visualizes the polymeric (F) actin. Indeed, when cells were stained with rhodamineconjugated phalloidin, F-actin was also detected on the osmopodia. However, even though all iPS cell populations tested here showed a strong positivity in staining for the GFP-reporter gene, this green fluorescent protein (which localizes in the nuclei as well as in the cytoplasm) was not detected in the osmopodia (Fig. 5E and F) . In Fig. 5 , the rhodamine/ phalloidin-stained iPS cells showed osmopodia extended at 30.5 mM osmolarity (Fig. 5B, C and G) . Interestingly, the podia anchored to other cells or to the surface of the culture plate, forming structures similar to tenupodia (arrows in Fig. 5I ) [28] . Tenupodia are thin, linear segments that bifurcate multiple times [28] , and are suggested to play both sensory and mechanical roles during migration and homing of hematopoietic stem cells [28] .
Hyperosmolarity-induced skeleton remodeling is associated with de novo F-actin assembly in iPS cells
We assessed whether the effect of hyperosmolarity on the actin skeleton is associated with the de novo assembly of F-actin. Changes in F-actin versus G-actin were quantified by Western blotting using a G-actin/F-actin assay (as reported in Materials and methods section) ( Fig. 6 ). In iPS cells exposed to HG (30.5 mM glucose) and HM (5.5 mM glucose + 25 mM mannitol), hyperosmolarity induced significant F-actin polymerization, as determined by a 2-fold increase in Factin (Fig. 6A) .
The integrity of the F-actin cytoskeleton is critically dependent on cell volume changes; several volume-regulated transport proteins, including water channels, exhibit functional interaction, with the cytoskeleton playing a pivotal role in cell volume regulation [30] . iPS cells (see Fig. 7A , online Supplement Figs. 2 and 3) and fibroblasts before transduction [31] express AQP1. To address the mechanism underlying the observed F-actin polymerization in iPS cells exposed to hyperosmolarity, we knocked down the AQP1 water channel using a pool of 3 different siRNA oligonucleotides. A significant suppression of AQP1 (about 90%) occurred in iPS cells transfected with siRNAs against AQP1. As a control for the specificity of the siRNA approach, we determined the expression of AQP1 after transfection with a scrambled sequence of siRNA serving as a sequence-unrelated control. AQP1 expression was essentially unchanged with the control reagents. Conversely, in iPS cells exposed to hyperosmolarity (HG: 30.5 mM glucose and HM: 5.5 mM glucose + 25 mM mannitol), the silencing of AQP1 prevented the de novo assembly of F-actin induced by hyperosmolarity (Fig. 6B) . Taken together, these experiments suggest that hyperosmolarity promotes de novo F-actin assembly, and that AQP1 is an important contributor to the hyperosmolar F-actin response.
AQP1 is expressed in iPS cells and affects their migration potential
Because AQP1 has been demonstrated to mediate the effects of hyperosmolarity [32] and to be involved in cell migration [33] , we investigated the effect of this water channel on cell migration in iPS cells. As shown in Fig. 7A, B and D, 24 h exposure of iPS cells to a hyperosmolar medium by the addition of glucose or mannitol (30.5 mM) increased AQP1 expression at immunoprecipitation. We seeded iPS cells on Matrigel after incubation with high glucose or high mannitol in the presence or absence of AQP1 silencing. In this functional assay of cell migration, iPS cells formed bundles in methylcellulose matrix and tubing networks in Matrigel, and high glucose or high mannitol produced the highest number of network formations (Fig. 7E and F) . Fig. 6 . The effect of AQP1 on G/F actin redistribution in human induced pluripotent stem cells exposed to high glucose-induced hyperosmolar stress. Serum-starved iPS cells were transfected with a pool of siRNAs to AQP1 or siRNAs to a scrambled sequence for 24 h, and then incubated for 24 h with high glucose (HG, 30.5 mmol/L) or high mannitol (HM, 5.5 mM glucose + 25 mM mannitol). At the end of treatment, the G-versus F-actin content was quantified by scanning densitometry on Western blot bands as detailed in Materials and methods section. Panel A shows increased expression of F-actin versus G-actin in iPS cells exposed to high glucose or high mannitol. The silencing of AQP1 (panel B) reverts the G/F actin redistribution. Representative immunoblots from 3 different experiments are shown. **, p b 0.01 F-actin vs G-actin; # , p b 0.01 vs non-stimulated iPS cells. did not modify the migration capacity of iPS cells. Taken together, these data indicate that hyperosmolarity influences the migration capacity of iPS cells primarily through the activation of upstream mediators of hyperosmolarity, such as AQP1.
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Beta-catenin co-immunoprecipitates with AQP1 in iPS cells exposed to hyperosmolarity β-Catenin has been reported to promote actin reorganization and is required for the organization of the cytoskeleton [34] . β-Catenin can recruit cell adhesion molecules, receptors, ion channels and signaling proteins [35] . We therefore investigated the possible interaction between the water channel AQP1 and β-catenin, and some of the downstream signaling of AQP1 in iPS cells exposed to hyperosmolarity. We tested this interaction by using co-immunoprecipitation to determine whether β-catenin is a component of an AQP1-containing complex. When confluent iPS cell lysates were immunoprecipitated with an AQP1antibody (but not with a pre-immune serum), β-catenin was coimmunoprecipitated, thus suggesting that β-catenin interacts with AQP1 ( Fig. 7C and D) . Twenty-four-hour exposure of iPS cells to a hyperosmolar medium by the addition of glucose or mannitol (at 30.5 mM) increased the expression of β-catenin in the AQP1 immunoprecipitates ( Fig. 7C and D) . Because β-catenin immunoprecipitates with AQP1, we analyzed the effect of AQP1 silencing on β-catenin expression. To specifically block AQP1, again we targeted disruption of AQP1 gene expression using 3 different species of siRNAs. In the immunoprecipitation experiments, treatment with AQP1 siRNAs resulted in a substantial (N 90%) reduction in AQP1 protein expression ( Fig. 7B and  D) . Proteins from AQP1 siRNA-transfected cells were then probed for β-catenin abundance. β-Catenin expression in high glucose-and high mannitol-treated cells, as well as in cells at baseline, was substantially suppressed after transfection with siRNAs against AQP1 ( Fig. 7C and D) .
Discussion
The present study reports novel findings regarding the effect of environmental conditions simulating diabetes in vitro, i.e. high glucose and hyperosmolarity, in human iPS cells. Here we demonstrate that concentrations of glucose up to 30.5 mM, attainable under hyperglycemic conditions, induce F-actin and cytoskeleton remodeling in human iPS cells through an AQP1-dependent hyperosmolar mechanism and, through this mechanism, promote cell migration. These effects depend on the hyperosmolar component of hyperglycemia rather than on hyperglycemia per se, as they are mimicked by the exposure of cells to the metabolically inactive monosaccharide mannitol. Currently available knowledge relates to the effects of high glucose on stem and progenitor cells [18, 36] , and there are no studies examining the effects of this harmful environmental condition and the resultant hyperosmolarity on iPS cell fate, proliferation and migration. At the same time, there is little knowledge of the underlying mechanisms by which biophysical (in this case hyperosmolarity) or biochemical signals (i.e., high glucose concentrations, simulating hyperglycemia, independent of hyperosmolarity) are transduced in changing the characteristics and responses of iPS cells. We here demonstrate for the first time that iPS cells are osmotically sensitive because capable of sensing and responding to hyperosmolarity, firstly by changing size and water permeability, secondly by forming osmopodia and tenupodia-like structures, and finally by expressing protein targets of hyperosmolarity, such as AQP1. Osmopodia and tenupodia in iPS cells may play a role in migration, long distance cell-cell interaction, or even controlling cell death processes. Immunofluorescence images of iPS cells revealed that actin is present in these structures. Further investigation is required to determine their physiological function.
From a molecular biology perspective, cellular responses to hyperosmolarity are compensatory molecular adaptations that allow the reestablishing of homeostasis [37] . AQP1 is a water channel protein expressed widely in vascular endothelia and fibroblasts, where it increases cell membrane water permeability and migration [33, 37] . AQP1 protein is expressed strongly in human and animal models of highly proliferating microvessels, such as malignant brain tumors [38] and the chorioallantoic membrane of the chick embryo [39] . In iPS cells, AQP1 is an upstream mediator of hyperosmolarity, and may represent a form of memory that these cells retain from the fibroblasts from which they originate.
We show here that knock-down of AQP1 prevents the F-actin reorganization and iPS cell migration induced by hyperosmolarity. In nonsilenced iPS cells, actin was mostly expressed as polymeric (F) actin, located in the cytoskeleton, and cells were able to migrate and organize a pseudo-vascular network in the Matrigel model of in vitro angiogenesis used by us. In contrast, iPS cells treated with siRNA against AQP1 expressed mostly monomeric (G) actin in the cytosol and lose the capacity to organize such a network of filaments. Thus, water entry in response to hyperosmolarity may create local osmotic gradients driving actin polymerization and cell movement. This is consistent with previous findings in other cell types, such as peritoneal mesothelial and ascitic cells [20, 40] , human melanoma cells [41] , leukocytes and microglia during autoimmune neuro-inflammation [42, 43] , corneal keratinocytes [44] and retinal cells in diabetes [45] . Thus, from a functional point of view, AQP1-silenced iPS cells decrease their capacity to migrate.
Another important finding of our work is the demonstration that AQP1 interacts with β-catenin, and this interaction is further enhanced in response to hyperosmolarity. In the canonical Wnt1/β-catenin pathway, Wnt1 ligand determines nuclear translocation of β-catenin, resulting in the regulation of gene transcription involved in cell proliferation and differentiation [46] . Recently it has been shown that Wnt1/βcatenin signaling enhances the induction of iPS cells at early stages of reprogramming [47] . After translocation in the nuclei, β-catenin interacts with the reprogramming factors KLF4, OCT4, AND SOX2, further enhancing the expression of pluripotency genes [47] . In the non-canonical Wnt1 pathway, which is mediated by the intracellular accumulation of calcium ions, Wnt1 ligand determines the nuclear translocation of transcription factor Nuclear Factor of Activated T-cells (NFAT), resulting in a suppression of β-catenin-dependent transcription, and activation of the small GTPase Cdc42, involved in the remodeling of the actin cytoskeleton, as well as the regulation of cell shape and cell migration [48] [49] [50] . Canonical and non-canonical Wnt1 pathways seem to have opposite effects on iPS cells and stem cells, since the activation of the former would lead to induction of reprogramming [47] , while activation of the latter would enhance changes in cell shape, adhesion and migration [51] .
We have previously observed (data not shown) that in endothelial cells and iPS cells hyperosmolarity increases the expression of NFAT and its nuclear translocation, suggesting an activation of the noncanonical Wnt1 pathway in cells exposed to hyperosmolarity.
Our data, showing interaction between AQP1 and β-catenin, would indicate that the cellular redistribution of β-catenin from the nuclei to the cytoplasma is a consequence of hyperosmolarity, with a reduction of the proportion of β-catenin free to translocate into the nuclei. Therefore the interaction between AQP1 and β-catenin is probably a secondary effect, rather than the direct consequence of osmolarity changes. On the contrary, activation of the non-canonical Wnt signaling pathway would be the primary effect of hyperosmolarity, and may represent the putative intracellular mechanism and the main downstream mediator of hyperosmolarity effects on iPS cell adhesion and migration. The effects of hyperosmolarity on canonical as well as non-canonical Wnt pathways need however to be further characterized.
Taken together, these data show that AQP1 is a critical component for the assembly of a plasma membrane-associated multiprotein complex, of which β-catenin is an important component; and that AQP1 mediates the stimulatory effect of hyperosmolarity on the cytoskeletal reorganization and motility of iPS cells. Interestingly, high glucose, but not high mannitol, which is devoid of glucose metabolic effect, positively affected gene expression of pluripotency markers in iPS cells. This finding is supported by previous literature reporting an increase in the reprogramming efficiency of iPS cells under high-glucose conditions [14, 52, 53] (reviewed in [18] ). It has indeed been shown that somatic reprogramming and pluripotency are characterized by a transition from oxidative metabolism to anaerobic glycolysis [14] . A high concentration of glucose in the culture medium stimulates the glycolytic flux, which guarantees the production of sufficient amounts of ATP to meet the metabolic requirements of proliferating cells [54] .
The generation of iPS cells from patients or healthy donors offers a disease model in which the patterns of growth, apoptosis and differentiation, as well as physiological responses to environmental factors such as elevated glucose concentrations and the resultant hyperosmolarity (both common in diabetes) can be analyzed. Although we acknowledge a limitation in our studies in not having a direct in vivo transferability, because we did not use fibroblasts derived from diabetic patients, the derivation of iPS cells from commercially available human fibroblasts has allowed us to analyze, in a selective manner, the effect of two main playershyperglycemia and hyperosmolarityin the diabetic microenvironment. Our studies therefore demonstrate how iPS cells may serve as in vitro disease model useful for the selective assessment of the cellular response of stem cells to environmental factors that can play a role in pathopysiological conditions, such as overt diabetes. Understanding the molecular and cellular responses of iPS cells in normal and disease conditions will help in generating autologous human iPS cell lines from healthy donors or diabetic patients for future therapeutic developments.
